On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...